861 related articles for article (PubMed ID: 29489750)
1. The SMAD2/3 interactome reveals that TGFβ controls m
Bertero A; Brown S; Madrigal P; Osnato A; Ortmann D; Yiangou L; Kadiwala J; Hubner NC; de Los Mozos IR; Sadée C; Lenaerts AS; Nakanoh S; Grandy R; Farnell E; Ule J; Stunnenberg HG; Mendjan S; Vallier L
Nature; 2018 Mar; 555(7695):256-259. PubMed ID: 29489750
[TBL] [Abstract][Full Text] [Related]
2. The crosstalk between RNA m
Li L; Chen YX; Yang B; Liao JY; Peng JW; Zhu S
Gene; 2020 May; 738():144483. PubMed ID: 32070750
[TBL] [Abstract][Full Text] [Related]
3. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state.
Sakaki-Yumoto M; Liu J; Ramalho-Santos M; Yoshida N; Derynck R
J Biol Chem; 2013 Jun; 288(25):18546-60. PubMed ID: 23649632
[TBL] [Abstract][Full Text] [Related]
4. Activin/nodal signaling and NANOG orchestrate human embryonic stem cell fate decisions by controlling the H3K4me3 chromatin mark.
Bertero A; Madrigal P; Galli A; Hubner NC; Moreno I; Burks D; Brown S; Pedersen RA; Gaffney D; Mendjan S; Pauklin S; Vallier L
Genes Dev; 2015 Apr; 29(7):702-17. PubMed ID: 25805847
[TBL] [Abstract][Full Text] [Related]
5. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.
Vallier L; Mendjan S; Brown S; Chng Z; Teo A; Smithers LE; Trotter MW; Cho CH; Martinez A; Rugg-Gunn P; Brons G; Pedersen RA
Development; 2009 Apr; 136(8):1339-49. PubMed ID: 19279133
[TBL] [Abstract][Full Text] [Related]
6. Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors.
Brown S; Teo A; Pauklin S; Hannan N; Cho CH; Lim B; Vardy L; Dunn NR; Trotter M; Pedersen R; Vallier L
Stem Cells; 2011 Aug; 29(8):1176-85. PubMed ID: 21630377
[TBL] [Abstract][Full Text] [Related]
7. TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells.
Osnato A; Brown S; Krueger C; Andrews S; Collier AJ; Nakanoh S; Quiroga Londoño M; Wesley BT; Muraro D; Brumm AS; Niakan KK; Vallier L; Ortmann D; Rugg-Gunn PJ
Elife; 2021 Aug; 10():. PubMed ID: 34463252
[TBL] [Abstract][Full Text] [Related]
8. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells.
James D; Levine AJ; Besser D; Hemmati-Brivanlou A
Development; 2005 Mar; 132(6):1273-82. PubMed ID: 15703277
[TBL] [Abstract][Full Text] [Related]
9. Interactions, localization, and phosphorylation of the m
Schöller E; Weichmann F; Treiber T; Ringle S; Treiber N; Flatley A; Feederle R; Bruckmann A; Meister G
RNA; 2018 Apr; 24(4):499-512. PubMed ID: 29348140
[No Abstract] [Full Text] [Related]
10. Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells.
Guzman-Ayala M; Lee KL; Mavrakis KJ; Goggolidou P; Norris DP; Episkopou V
PLoS One; 2009; 4(1):e4268. PubMed ID: 19172185
[TBL] [Abstract][Full Text] [Related]
11. Graded Nodal/Activin signaling titrates conversion of quantitative phospho-Smad2 levels into qualitative embryonic stem cell fate decisions.
Lee KL; Lim SK; Orlov YL; Yit le Y; Yang H; Ang LT; Poellinger L; Lim B
PLoS Genet; 2011 Jun; 7(6):e1002130. PubMed ID: 21731500
[TBL] [Abstract][Full Text] [Related]
12. A novel nodal enhancer dependent on pluripotency factors and smad2/3 signaling conditions a regulatory switch during epiblast maturation.
Papanayotou C; Benhaddou A; Camus A; Perea-Gomez A; Jouneau A; Mezger V; Langa F; Ott S; Sabéran-Djoneidi D; Collignon J
PLoS Biol; 2014 Jun; 12(6):e1001890. PubMed ID: 24960041
[TBL] [Abstract][Full Text] [Related]
13. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
Kato Y; Habas R; Katsuyama Y; Näär AM; He X
Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
[TBL] [Abstract][Full Text] [Related]
14. Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-beta signaling.
Dai F; Lin X; Chang C; Feng XH
Dev Cell; 2009 Mar; 16(3):345-57. PubMed ID: 19289081
[TBL] [Abstract][Full Text] [Related]
15. Brd4-Brd2 isoform switching coordinates pluripotent exit and Smad2-dependent lineage specification.
Fernandez-Alonso R; Davidson L; Hukelmann J; Zengerle M; Prescott AR; Lamond A; Ciulli A; Sapkota GP; Findlay GM
EMBO Rep; 2017 Jul; 18(7):1108-1122. PubMed ID: 28588073
[TBL] [Abstract][Full Text] [Related]
16. Marrow mesenchymal stem cell mediates diabetic nephropathy progression via modulation of Smad2/3/WTAP/m6A/ENO1 axis.
Bai Y; Huang L; Fan Y; Li Y
FASEB J; 2024 Jun; 38(11):e23729. PubMed ID: 38847786
[TBL] [Abstract][Full Text] [Related]
17. Human m
Wang X; Huang J; Zou T; Yin P
RNA Biol; 2017 Mar; 14(3):300-304. PubMed ID: 28121234
[TBL] [Abstract][Full Text] [Related]
18. Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.
Beyer TA; Weiss A; Khomchuk Y; Huang K; Ogunjimi AA; Varelas X; Wrana JL
Cell Rep; 2013 Dec; 5(6):1611-24. PubMed ID: 24332857
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response.
Tu AW; Luo K
J Biol Chem; 2007 Jul; 282(29):21187-96. PubMed ID: 17478422
[TBL] [Abstract][Full Text] [Related]
20. Polycomb determines responses to smad2/3 signaling in embryonic stem cell differentiation and in reprogramming.
Dahle O; Kuehn MR
Stem Cells; 2013 Aug; 31(8):1488-97. PubMed ID: 23666711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
